ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 148,06
-0,49%
Dow Jones
39 869,38
0,00%
DAX
18 683,30
-0,23%
Brent Oil
83,495
0,35%
Bitcoin
66 436,56
1,84%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Quanterix Corporation (QTRX)

  7. Quanterix Corporation (QTRX) Actualités

QTRX

Quanterix (QTRX)

Quanterix Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:QTRX
DateHeureSourceTitreSymboleSociété
16/05/202422h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:QTRXQuanterix Corporation
08/05/202420h55Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:QTRXQuanterix Corporation
07/05/202422h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:QTRXQuanterix Corporation
07/05/202422h00Business WireQuanterix Releases Financial Results for the First Quarter of 2024NASDAQ:QTRXQuanterix Corporation
29/04/202422h00Business WireQuanterix To Report First Quarter 2024 Financial ResultsNASDAQ:QTRXQuanterix Corporation
21/03/202422h30Business WireQuanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer’s Disease Testing InfrastructureNASDAQ:QTRXQuanterix Corporation
04/03/202423h27Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:QTRXQuanterix Corporation
04/03/202415h00Business WireQuanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer’s DiseaseNASDAQ:QTRXQuanterix Corporation
29/02/202422h58Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:QTRXQuanterix Corporation
29/02/202422h00Business WireQuanterix Releases Operating Results for Fourth Quarter and Full Year 2023NASDAQ:QTRXQuanterix Corporation
27/02/202400h58Business WireQuanterix Reschedules Q4 and Full Year 2023 Earnings Conference Call; Reaffirms 2023 GuidanceNASDAQ:QTRXQuanterix Corporation
26/02/202415h00Business WireQuanterix Announces First Collaborations with Five Health Networks to Aid the Diagnosis and Clinical Management of Individuals with Alzheimer’s DiseaseNASDAQ:QTRXQuanterix Corporation
23/02/202422h30Business WireQuanterix to Present at Cowen’s 44th Annual Health Care ConferenceNASDAQ:QTRXQuanterix Corporation
16/02/202422h00Business WireQuanterix Fourth Quarter Earnings and Full Year 2023 Financial Results Conference CallNASDAQ:QTRXQuanterix Corporation
14/02/202422h57Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:QTRXQuanterix Corporation
02/01/202423h21Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:QTRXQuanterix Corporation
12/12/202322h00Business WireQuanterix to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:QTRXQuanterix Corporation
13/11/202322h00Business WireQuanterix To Participate at The Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumNASDAQ:QTRXQuanterix Corporation
13/11/202313h00GlobeNewswire Inc.Sotera Health Appoints Karen Flynn to Board of DirectorsNASDAQ:QTRXQuanterix Corporation
06/11/202323h56Business WireQuanterix Releases Operating Results for Third Quarter 2023NASDAQ:QTRXQuanterix Corporation
06/11/202322h50Business WireQuanterix Releases Operating Results for Third Quarter 202NASDAQ:QTRXQuanterix Corporation
30/10/202321h00Business WireQuanterix to Report Third Quarter 2023 Financial Results on November 7, 2023NASDAQ:QTRXQuanterix Corporation
24/10/202322h30Business WireQuanterix Launches High Accuracy p-Tau 217 Blood Biomarker Test to Aid Physician Diagnosis of Alzheimer’s DiseaseNASDAQ:QTRXQuanterix Corporation
24/10/202302h30Business WireQuanterix Announces New Agreement to Advance Blood Based Alzheimer's Disease DetectionNASDAQ:QTRXQuanterix Corporation
28/09/202323h00Business WireQuanterix CEO to Speak at Goldman Sachs Alzheimer’s Disease DayNASDAQ:QTRXQuanterix Corporation
05/09/202314h00Business WireQuanterix to Participate at the Morgan Stanley 21st Annual Global Healthcare ConferenceNASDAQ:QTRXQuanterix Corporation
22/08/202323h02Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:QTRXQuanterix Corporation
21/08/202322h30Business WireWilliam P. Donnelly Appointed to Quanterix’s Board of DirectorsNASDAQ:QTRXQuanterix Corporation
09/08/202314h30Business WireQuanterix Appoints Vandana Sriram as Chief Financial OfficerNASDAQ:QTRXQuanterix Corporation
07/08/202323h13Business WireQuanterix Releases Operating Results for Second Quarter 2023NASDAQ:QTRXQuanterix Corporation
 Showing the most relevant articles for your search:NASDAQ:QTRX

Dernières Valeurs Consultées

LSE
0FJL
E Pairis
USOTC
ROYE
Royal Energy Resources (CE)
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés